Aclarion, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Aclarion, Inc. filed its quarterly report for the period ending June 30, 2026. The filing itself contains no disclosed financial data, material transactions, counterparties, dollar amounts, percentages, share counts, or business changes in the provided text—only document metadata, filing dates (August 6, 2026), and corporate registration information (Delaware incorporation, SIC 8071 medical laboratories, $4.4M market value).
Why this rating
Document is a routine periodic disclosure. No material events, transactions, or financial metrics disclosed. Standard 10-Q filing for micro-cap with minimal information provided.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.